Abbott recalls beetle-laced baby formula; Was Elan's governance report objective?;

 @FiercePharma: Layoffs return with Abbott's 3,000 job cuts. Article | Follow @FiercePharma

> Abbott Laboratories is voluntarily recalling millions of containers of its top-selling Similac powdered infant formulas after beetles were found in the products and in the Michigan plant where they are made. Abbott release | Report

> New questions have arisen about the independence of a report prepared by a U.S. law firm that cleared Irish drugmaker Elan of any breaches of corporate governance or other wrongdoing. Report

> Janssen U.K. plans to launch a wide-ranging social media campaign to raise awareness of the chronic skin condition psoriasis. Report

> The European Commission has cleared Deutsche Bank's planned acquisition of Icelandic generics maker Actavis. Report

> Biovail and Valeant Pharmaceuticals expect their $3.2-billion merger will be completed by September 28, earlier than many on the Street anticipated. Report

> Bayer says it is launching Betaferon for the treatment of relapsing-remitting forms of multiple sclerosis in China. Report

> Even before Watson Pharmaceuticals' new emergency contraceptive ella arrives on U.S. pharmacy shelves, opponents are campaigning to persuade pharmacists not to fill prescriptions for the drug. Report

> Goldman Sachs analyst Mark Beards cut his rating on Novartis (NVS) to "Neutral" from "Buy," listing the company among the Big Pharma outfits most exposed to a looming disaster at the hands of generic drugs. Report

Biotech News

@FierceBiotech: Novartis wins landmark approval for oral MS drug. Article | Follow @FierceBiotech

 @JohnCFierce: Lundbeck is cutting its R&D staff while shifting to more collaborations on brain diseases. Article | Follow @JohnCFierce

> BioMed raising cash is it wheels and deals on biotech campuses. News

> Third Rock leads $30M round for antibody upstart. Article

> Reata scores $450M in quick cash from Abbott pact. News

Vaccines News

> Cervical cancer vax ready to enter human trials. News

> IDT expands vax manufacturing and workforce. Story

> Plant-based H1N1 vax starts clinical trial. Report

> Breast cancer vax could protect women from their 40s. Article

Manufacturing News

> Newly posted warning cites repeat violation. Story

> Pfizer, Sproxil aid in safe drug access programs. Article

> Report: DEA wants controls on propofol. News

> Google sues online merchants of drug fakes. Story

And Finally... The raised risk of cancer in people using insulin decreases over time, a large study showed, announced Novo Nordisk, the world's biggest maker of insulin. Report

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.